Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial

Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial

The narrow range of choice and virus resistance to the most common drugs require search and introduction of new drugs with proven efficacy and safety for the treatment of influenza. Ergoferon is a new combined medicine containing release active antibodies to interferon-γ (anti-IFNγ), CD4-coreceptor...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Averyanov, A. P. Babkin, B. Ya. Bart, A. L. Volchetsky, E. S. Minina, O. A. Kozyrev, M. P. Kostinov, D. V. Petrov, E. P. Selkova, M. A. Putilovsky, V. B. Nechaev, O. I. Epstein, E. N. Andrianova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	influenza antiviral drugs fever ergoferon release active antibodies
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/445
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ergoferon Liquid Dosage Form - Efficacious and Safe Treatment for Childhood Acute Respiratory Infections. Interim Outcomes of a Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: N. A. Geppe, et al.
Published: (2020-05-01)

Ergoferon and Improvement of Etiopathogenetic Therapy of Influenza and Acute Respiratore Viral Infection in Adults
by: V. K. Verevshchikov, et al.
Published: (2020-05-01)

The use of Different Schemes of Antiviral Therapy of Acute Respiratory Viral Infection in Children
by: A. L. Zaplatnikov, et al.
Published: (2015-10-01)

Comprehensive Evaluation of Several Treatment Combinations Used to Manage Acute Respiratory Infections in Routine Paediatric Practice
by: E. G. Kondyurina, et al.
Published: (2020-05-01)

ANTI-INFLAMMATORY AND ANTI-ALLERGIC FEATURES OF ANTIBODIES TO HISTAMINE IN RELEASE-ACTIVE FORM: REVIEW OF EXPERIMENTAL AND CLINICAL RESEARCHES
by: E. S. Zhavbert, et al.
Published: (2015-08-01)

NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN
by: I. V. Nikolaeva
Published: (2015-08-01)

Evaluating Changes in the Clinical Presentation of Acute Obstructive Bronchitis in Preschool Children Using Antiviral Therapy
by: E. G. Kondyurina, et al.
Published: (2020-05-01)

OSELTAMIVIR IN PEDIATRIC PRACTICES (WORLD'S APPLICATION EXPERIENCE)
by: A.S. Kolbin, et al.
Published: (2008-11-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
by: A.B. Ivanyuk, et al.
Published: (2008-01-01)

Evaluation of the Efficacy of Riamilovir and Oseltamivir Combination on the Experimental Model of Mice Influenza Infection
by: I. N. Falynskova, et al.
Published: (2020-05-01)

OSELTAMIVIR IN FLU TREATMENT AND PREVENTION AMONG CHILDREN
by: T.V. Kulichenko, et al.
Published: (2007-12-01)

EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN
by: A.S. Darmanyan
Published: (2007-10-01)

OSELTAMIVIR AS ANTIVIRAL THERAPY OF INFLUENZA A(H1N1)pdm09 IN CHILDREN AND ADULTS
by: L. V. Osidak, et al.
Published: (2016-09-01)

Treatment of acute respiratory infection in adults: results of a multicenter randomized double-blind placebo-controlled clinical trial
by: M. P. Kostinov, et al.
Published: (2021-06-01)

Impact of Oseltamivir and Diabetes Development
by: Bor-Show Tzang, et al.
Published: (2025-01-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Effect of Oseltamivir Use on Follow-Up Stroke Mortality
by: Pei-Hua Chuang, et al.
Published: (2025-05-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Strategies for the Use of Oseltamivir and Zanamivir during Pandemic Outbreaks
by: Elsa Hansen, et al.
Published: (2010-01-01)

Problems of Providing Epidemiological Safety of Nonsterile Endoscopic Interventions
by: T. A. Grenkova, et al.
Published: (2015-12-01)

Evaluation of the efficacy of triazavirin versus oseltamivir in management of COVID-19
by: Sara Samir Mohamed Elmenshawy, et al.
Published: (2024-12-01)

Synthesis, Isolation and Characterization of Process-Related Impurities in Oseltamivir Phosphate
by: Yogesh Kumar Sharma, et al.
Published: (2012-01-01)

Safety of pertussis vaccines for adolescents
by: M. P. Kostinov, et al.
Published: (2020-10-01)

Clinical and Virologic Outcomes of Baloxavir Compared with Oseltamivir in Pediatric Patients with Influenza in Japan
by: Nobuhisa Ishiguro, et al.
Published: (2025-03-01)

Oseltamivir use in infants under one year of age: are there still unanswered questions?
by: Ateş Kara, et al.
Published: (2012-02-01)

Clinical efficacy of baloxavir marboxil versus oseltamivir in kidney transplant recipients with influenza
by: Jiali Jiang, et al.
Published: (2025-07-01)

Improvement of Natural Resistance in Children for Prophylaxis of Influenza and Acute Respiratory Tract Viral Infections (Results of Multicentre Randomized Trials)
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Effects of the fixed-dose combination therapy with indapamide and valsartan on renal function in patients with Type 2 diabetes mellitus and arterial hypertension
by: T. V. Malykh, et al.
Published: (2011-12-01)

INCREASED ANTI-INFLUENZA EFFICACY OF OSELTAMIVIR (TAMIFLU<sup>®</sup>) AND UMIFENOVIR (ARBIDOL<sup>®</sup>) BY COMBINED USE WITH KAGOCEL<sup>®</sup>
by: A. F. Popov, et al.
Published: (2020-05-01)

Condition of the uvula and soft palate as an indicator of ventral branch of the vagus nerve function and neurological disorganization in dentists and dental students
by: P. I. Petrov, et al.
Published: (2021-11-01)

Neuropsychiatric problems due to oseltamivir treatment in H7N9 bird flu
by: Viroj Wiwanitkit
Published: (2014-02-01)

Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system.
by: Lurong Yu, et al.
Published: (2025-01-01)

Inflammation laryngeal changes in common cold children
by: E. P. Selkova, et al.
Published: (2014-09-01)

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.
by: Anthony C Marriott, et al.
Published: (2014-01-01)

FEATURES OF NK-CELL CONTENTS IN PATIENTS WITH CHRONIC HEPATITIS C
by: M. S. Selkova, et al.
Published: (2014-07-01)

Immunogenicity and Clinical Efficacy Combined Vaccine against Diphtheria, Tetanus and Hepatitis B in Patients with Chronic Obstructive Pulmonary Disease
by: M. P. Kostinov, et al.
Published: (2017-08-01)

Use of inhibitors of tumor necrosis factor α in women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2021-10-01)

COVID-19 in women with ankylosing spondylitis during pregnancy and within one year after childbirth
by: O. A. Krichevskaya, et al.
Published: (2022-09-01)

Isoprinosine along with Favipiravir or Oseltamivir in Patients with Moderate Covid-19 at RSD Dr. Soebandi Jember
by: Chrysnanda Maryska, et al.
Published: (2022-12-01)